Skip to NavigationSkip to content

Pharmafile - Research and Development News

Novo Nordisk's Victoza (liraglutide)
Could boost Novo Nordisk’s chances of gaining a new licence for its diabetes drug
Halts part of Tyverb phase III programme
TAK-875 is being tested in patients with type II diabetes
UK pharma 'part of the solution, not the problem'
Includes social media for patient recruitment, a service deal between BMS and Icon, plus updates from Clinilabs, RxGen and Parexel
First 'collaborative development' agreement will underwrite phase III cancer studies
Report questions the use of placebo controls in regulatory submissions
Company rumoured to be interested in MN Pharmaceuticals
Eisai releases phase III results of epilepsy trial
Pfizer Sandwich Kent
The Research Network will focus on outsourcing services
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches